Trio-Tech International 10-Q for FY2023 Q1
Trio-Tech International (TRT)
About this 10-Q
Trio-Tech International filed this 10-Q on November 10, 2022, covering the quarter ended September 30, 2022 (FY2023 Q1).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $11.94M
- up 17.4% from $10.17M a year earlier
- Net income
- $882K
- down 3.8% from net income of $917K a year earlier
- Diluted EPS
- $0.21
- down 8.7% from $0.23 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For the Quarterly Period Ended
OR
For the Transition Period from ___ to ___
Commission File Number
TRIO-TECH INTERNATIONAL
(Exact name of Registrant as specified in its Charter)
| |
| |
| (State or other jurisdiction of |
| (I.R.S. Employer |
| incorporation or organization) |
| Identification Number) |
|
|
|
|
| |
|
|
| Unit 03-09 |
| |
| (Address of principal executive offices) |
| (Zip Code) |
Registrant's Telephone Number, Including Area Code: (
Securities registered pursuant to Section 12(b) of the Act:
| Name of each exchange | ||
| Title of each class | Trading Symbol | on which registered |
| | | |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
| Large Accelerated Filer | ☐ | Accelerated Filer | ☐ | |
| | ☐ | Smaller reporting company | | |
| Emerging growth company | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of November 1, 2022, there were
INDEX TO CONDENSED CONSOLIDATED FINANCIAL INFORMATION, OTHER INFORMATION AND SIGNATURE
FORWARD-LOOKING STATEMENTS
The discussions of Trio-Tech International’s (the “Company”) business and activities set forth in this Quarterly Report on Form 10-Q (this “Quarterly Report”) and in other past and future reports and announcements by the Company may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and assumptions regarding future activities and results of operations of the Company. In light of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, the following factors, among others, could cause actual results to differ materially from those reflected in any forward-looking statements made by or on behalf of the Company: market acceptance of Company products and services; changing business conditions or technologies and volatility in the semiconductor industry, which could affect demand for the Company’s products and services; the impact of competition; problems with technology; product development schedules; delivery schedules; changes in military or commercial testing specifications which could affect the market for the Company’s products and services; difficulties in profitably integrating acquired businesses, if any, into the Company; risks associated with conducting business internationally and especially in Asia, including currency fluctuations and devaluation, currency restrictions, local laws and restrictions and possible social, political and economic instability; changes in U.S. and global financial and equity markets, including market disruptions and significant interest rate fluctuations; ongoing public health issues related to the COVID-19 pandemic; the trade tension between U.S. and China; other economic, financial and regulatory factors beyond the Company’s control and uncertainties relating to our ability to operate our business in China; uncertainties regarding the enforcement of laws and the fact that rules and regulation in China can change quickly with little advance notice, along with the risk that the Chinese government may intervene or influence our operation at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers could result in a material change in our operations, financial performance and/or the value of our common stock, no par value (“Common Stock”) or impair our ability to raise money. Other than statements of historical fact, all statements made in this Quarterly Report are forward-looking, including, but not limited to, statements regarding industry prospects, future results of operations or financial position, and statements of our intent, belief and current expectations about our strategic direction, prospective and future financial results and condition. In some cases, you can identify forward-looking statements by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “estimates,” “potential,” “believes,” “can impact,” “continue,” or the negative thereof or other comparable terminology. Forward-looking statements involve risks and uncertainties that are inherently difficult to predict, which could cause actual outcomes and results to differ materially from our expectations, forecasts and assumptions.
Unless otherwise required by law, we undertake no obligation to update forward-looking statements to reflect subsequent events, changed circumstances, or the occurrence of unanticipated events. You are cautioned not to place undue reliance on such forward-looking statements.
ITEM 1. FINANCIAL STATEMENTS
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS, EXCEPT NUMBER OF SHARES)
| September 30, | June 30, | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| CURRENT ASSETS: | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Short-term deposits | ||||||||
| Trade accounts receivable, less allowance for doubtful accounts of $ and $, respectively | ||||||||
| Other receivables | ||||||||
| Inventories, less provision for obsolete inventories of and $, respectively | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Financed sales receivable | ||||||||
| Total current assets | ||||||||
| NON-CURRENT ASSETS: | ||||||||
| Deferred tax assets | ||||||||
| Investment properties, net | ||||||||
| Property, plant and equipment, net | ||||||||
| Operating lease right-of-use assets | ||||||||
| Other assets | ||||||||
| Financed sales receivable | ||||||||
| Restricted term deposits | ||||||||
| Total non-current assets | ||||||||
| TOTAL ASSETS | $ | $ | ||||||
| LIABILITIES | ||||||||
| CURRENT LIABILITIES: | ||||||||
| Lines of credit | $ | $ | ||||||
| Accounts payable | ||||||||
| Accrued expenses | ||||||||
| Income taxes payable | ||||||||
| Current portion of bank loans payable | ||||||||
| Current portion of finance leases | ||||||||
| Current portion of operating leases | ||||||||
| Total current liabilities | ||||||||
| NON-CURRENT LIABILITIES: | ||||||||
| Bank loans payable, net of current portion | ||||||||
| Finance leases, net of current portion | ||||||||
| Operating leases, net of current portion | ||||||||
| Income taxes payable, net of current portion | ||||||||
| Deferred tax liabilities | ||||||||
| Other non-current liabilities | ||||||||
| Total non-current liabilities | ||||||||
| TOTAL LIABILITIES | $ | $ | ||||||
| EQUITY | ||||||||
| TRIO-TECH INTERNATIONAL’S SHAREHOLDERS’ EQUITY: | ||||||||
| Common stock, par value, shares authorized; and shares issued outstanding as at September 30 and June 30, 2022 | $ | |||||||
| Paid-in capital | ||||||||
| Accumulated retained earnings | ||||||||
| Accumulated other comprehensive income-translation adjustments | ||||||||
| Total Trio-Tech International shareholders’ equity | ||||||||
| Non-controlling interest | ||||||||
| TOTAL EQUITY | $ | $ | ||||||
| TOTAL LIABILITIES AND EQUITY | $ | $ | ||||||
See notes to condensed consolidated financial statements
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS)
UNAUDITED (IN THOUSANDS, EXCEPT EARNINGS PER SHARE)
| Three Months Ended | ||||||||
| Sept. 30, | Sept. 30, | |||||||
| Revenue | ||||||||
| Manufacturing | $ | $ | ||||||
| Testing services | ||||||||
| Distribution | ||||||||
| Real estate | ||||||||
| Cost of Sales | ||||||||
| Cost of manufactured products sold | ||||||||
| Cost of testing services rendered | ||||||||
| Cost of distribution | ||||||||
| Cost of real estate | ||||||||
| Gross Margin | ||||||||
| Operating Expenses: | ||||||||
| General and administrative | ||||||||
| Selling | ||||||||
| Research and development | ||||||||
| Gain on disposal of property, plant and equipment | ||||||||
| Total operating expenses | ||||||||
| Income from Operations | ||||||||
| Other Income/(Expenses) | ||||||||
| Interest expenses | ( | ) | ( | ) | ||||
| Other income, net | ||||||||
| Total other income | ||||||||
| Income from Continuing Operations before Income Taxes | ||||||||
| Income Tax Expenses | ( | ) | ( | ) | ||||
| Income from Continuing Operations before Non-controlling Interest, Net of Tax | ||||||||
| Discontinued Operations | ||||||||
| Income from discontinued operations, net of tax | ||||||||
| NET INCOME | ||||||||
| Less: Net income attributable to the non-controlling interest | ||||||||
| Net Income Attributable to Trio-Tech International Common Shareholders | $ | $ | ||||||
| Amounts Attributable to Trio-Tech International Common Shareholders: | ||||||||
| Income from continuing operations, net of tax | ||||||||
| Income from discontinued operations, net of tax | ||||||||
| Net Income Attributable to Trio-Tech International Common Shareholders | $ | $ | ||||||
| Basic Earnings per Share: | ||||||||
| Basic earnings per share from continuing operations attributable to Trio-Tech International | $ | $ | ||||||
| Basic earnings per share from discontinued operations attributable to Trio-Tech International | $ | $ | ||||||
| Basic Earnings per Share from Net Income Attributable to Trio-Tech International | $ | $ | ||||||
| Diluted Earnings per Share: | ||||||||
| Diluted earnings per share from continuing operations attributable to Trio-Tech International | $ | $ | ||||||
| Diluted earnings per share from discontinued operations attributable to Trio-Tech International | $ | $ | ||||||
| Diluted Earnings per Share from Net Income Attributable to Trio-Tech International | $ | $ | ||||||
| Weighted average number of common shares outstanding | ||||||||
| Basic | ||||||||
| Dilutive effect of stock options | ||||||||
| Number of shares used to compute earnings per share diluted | $ | $ | ||||||
See notes to condensed consolidated financial statements.
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) / INCOME
UNAUDITED (IN THOUSANDS)
| Three Months Ended | ||||||||
| Sept. 30, | Sept. 30, | |||||||
| 2022 | 2021 | |||||||
| Comprehensive Income Attributable to Trio-Tech International Common | ||||||||
| Shareholders | ||||||||
| Net income | $ | $ | ||||||
| Foreign currency translation, net of tax | ( | ) | ( | ) | ||||
| Comprehensive (Loss) / Income | ( | ) | ||||||
| Less: Comprehensive income attributable to the non-controlling interests | ||||||||
| Comprehensive (Loss) / Income Attributable to Trio-Tech International Common Shareholders | $ | ( | ) | $ | ||||
See notes to condensed consolidated financial statements.
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
UNAUDITED (IN THOUSANDS)
Three months ended September 30, 2022
| Common Stock | Paid-in | Accumulated Retained | Accumulated Other Comprehensive | Non- controlling | ||||||||||||||||||||||||
| Shares | Amount | Capital | Earnings | Income/ (Loss) | Interest | Total | ||||||||||||||||||||||
| $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
| Balance at June 30, 2022 | ||||||||||||||||||||||||||||
| Stock option expenses | - | |||||||||||||||||||||||||||
| Net income | ||||||||||||||||||||||||||||
| Dividend declared by subsidiary | - | |||||||||||||||||||||||||||
| Exercise of stock option | ||||||||||||||||||||||||||||
| Translation adjustment | - | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||
| Balance at Sept 30, 2022 | ||||||||||||||||||||||||||||
Three months ended September 30, 2021
| Common Stock | Paid-in | Accumulated Retained | Accumulated Other Comprehensive | Non- controlling | ||||||||||||||||||||||||
| Shares | Amount | Capital | Earnings | Income/ (Loss) | Interest | Total | ||||||||||||||||||||||
| $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
| Balance at June 30, 2021 | ||||||||||||||||||||||||||||
| Stock option expenses | - | |||||||||||||||||||||||||||
| Net income | - | |||||||||||||||||||||||||||
| Translation adjustment | - | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||
| Balance at Sept. 30, 2021 | ||||||||||||||||||||||||||||
See notes to condensed consolidated financial statements.
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (IN THOUSANDS)
| Three Months Ended |
||||||||
| Sept. 30, |
Sept. 30, |
|||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) |
|||||||
| Cash Flow from Operating Activities |
||||||||
| Net income/ (loss) |
$ | $ | ||||||
| Adjustments to reconcile net income/(loss) to net cash flow provided by operating activities |
||||||||
| Depreciation and amortization |
||||||||
| Addition of provision for obsolete inventories |
( |
) | ||||||
| Stock option expense |
||||||||
| Bad debt recovery |
( |
) | ( |
) | ||||
| Accrued interest expense, net accrued interest income |
||||||||
| Payment of interest portion of finance lease |
( |
) | ( |
) | ||||
| Gain on sale of property, plant and equipment - continuing operations |
( |
) | ||||||
| Warranty recovery, net |
||||||||
| Deferred tax expense |
||||||||
| Changes in operating assets and liabilities, net of acquisition effects |
||||||||
| Trade accounts receivable |
( |
) | ( |
) | ||||
| Other receivables |
( |
) | ||||||
| Other assets |
( |
) | ||||||
| Inventories |
( |
) | ( |
) | ||||
| Prepaid expenses and other current assets |
( |
) | ||||||
| Accounts payable and accrued expenses |
||||||||
| Income taxes payable |
||||||||
| Operating lease liabilities |
( |
) | ( |
) | ||||
| Net Cash Provided by / (Used in) Operating Activities |
$ | $ | ( |
) | ||||
| Cash Flow from Investing Activities |
||||||||
| Withdrawal from unrestricted term deposits, net |
||||||||
| Additions to property, plant and equipment |
( |
) | ( |
) | ||||
| Net Cash Provided by Investing Activities |
||||||||
| Cash Flow from Financing Activities |
||||||||
| Payment on lines of credit |
( |
) | ( |
) | ||||
| Payment of bank loans |
( |
) | ( |
) | ||||
| Payment of finance leases |
( |
) | ( |
) | ||||
| Proceeds from exercising stock options |
||||||||
| Proceeds from lines of credit |
||||||||
| Proceeds from bank loans |
||||||||
| Net Cash (Used in) / Provided by Financing Activities |
( |
) | ||||||
| Effect of Changes in Exchange Rate |
( |
) | ( |
) | ||||
| Net Increase / (Decrease) in Cash, Cash Equivalents, and Restricted Cash |
( |
) | ||||||
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period |
||||||||
| Cash, Cash Equivalents, and Restricted Cash at End of Period |
$ | $ | ||||||
| Supplementary Information of Cash Flows |
||||||||
| Cash paid during the period for: |
||||||||
| Interest |
$ | $ | ||||||
| Income taxes |
$ | $ | ||||||
| Reconciliation of Cash, Cash Equivalents, and Restricted Cash |
||||||||
| Cash |
||||||||
| Restricted Term-Deposits in Non-Current Assets |
||||||||
| Total Cash, Cash Equivalents, and Restricted Cash Shown in Statements of Cash Flows |
$ | $ | ||||||
See notes to condensed consolidated financial statements.
Amounts included in restricted deposits represent the amount of cash pledged to secure loans payable or trade financing granted by financial institutions and serve as collateral for public utility agreements such as electricity and water. Restricted deposits are classified as non-current assets as they relate to long-term obligations and will become unrestricted only upon discharge of the obligations.
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS, EXCEPT EARNINGS PER SHARE AND NUMBER OF SHARES)
1. ORGANIZATION AND BASIS OF PRESENTATION
Trio-Tech International (the “Company”, or “TTI”) was incorporated in fiscal year ended June 30, 1958 under the laws of the State of California. TTI provides third-party semiconductor testing and burn-in services primarily through its laboratories in Southeast Asia. In addition, TTI operates testing facilities in the United States (“U.S.”). The Company also designs, develops, manufactures and markets a broad range of equipment and systems used in the manufacturing and testing of semiconductor devices and electronic components. In the first quarter of the fiscal year ended June 30, 2023 (“Fiscal 2023”), TTI conducted business in four business segments: Manufacturing, Testing Services, Distribution and Real Estate. TTI has subsidiaries in the U.S., Singapore, Malaysia, Thailand, Indonesia, Ireland and China as follows:
| Ownership | Location | |
| Express Test Corporation (Dormant) | | Van Nuys, California |
| Trio-Tech Reliability Services (Dormant) | | Van Nuys, California |
| KTS Incorporated, dba Universal Systems (Dormant) | | Van Nuys, California |
| European Electronic Test Centre (Dormant) | | Dublin, Ireland |
| Trio-Tech International Pte. Ltd. | | Singapore |
| Universal (Far East) Pte. Ltd.* | | Singapore |
| Trio-Tech International (Thailand) Co. Ltd. * | | Bangkok, Thailand |
| Trio-Tech (Bangkok) Co. Ltd. * | | Bangkok, Thailand |
| Trio-Tech (Malaysia) Sdn. Bhd. (55% owned by Trio-Tech International Pte. Ltd.) | | Penang and Selangor, Malaysia |
| Trio-Tech (Kuala Lumpur) Sdn. Bhd. | | Selangor, Malaysia |
| (100% owned by Trio-Tech Malaysia Sdn. Bhd.) | ||
| Prestal Enterprise Sdn. Bhd. | | Selangor, Malaysia |
| (76% owned by Trio-Tech International Pte. Ltd.) | ||
| Trio-Tech (SIP) Co., Ltd. * | | Suzhou, China |
| Trio-Tech (Chongqing) Co. Ltd. * | | Chongqing, China |
| SHI International Pte. Ltd. (Dormant) (55% owned by Trio-Tech International Pte. Ltd) | | Singapore |
| PT SHI Indonesia (Dormant) (100% owned by SHI International Pte. Ltd.) | | Batam, Indonesia |
| Trio-Tech (Tianjin) Co., Ltd. * | | Tianjin, China |
| Trio-Tech (Jiangsu) Co., Ltd. (51% owned by Trio-Tech (SIP) Co., Ltd.) | | Suzhou, China |
*
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements are presented in U.S. dollars unless otherwise stated. The accompanying condensed consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report for the fiscal year ended June 30, 2022 (“Fiscal 2022”). The Company’s operating results are presented based on the translation of foreign currencies using the respective quarter’s average exchange rate.
The results of operations for the three months ended September 30, 2022 are not necessarily indicative of the results that may be expected for any other interim period or for the full year ending June 30, 2023.
Use of Estimates — The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Among the more significant estimates included in these consolidated financial statements are the estimated allowance for doubtful account receivables, reserve for obsolete inventory, impairments, provision of income tax, stock options and the deferred income tax asset allowance. Actual results could materially differ from those estimates.
Significant Accounting Policies. There have been no material changes to our significant accounting policies summarized in Note 1 “Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated Financial Statements included in our Annual Report on Form 10-K for Fiscal 2022.
2. NEW ACCOUNTING PRONOUNCEMENTS
In March 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2022-02 updating Accounting Standards Codification (“ASC”) Topic 326: Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings (“TDR") and Vintage Disclosures (“ASU 2022-02”), which require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investment in leases within the scope of Subtopic 326-20. The Company has completed its assessment and concluded that ASU 2022-02 has no significant impact to the Company’s consolidated financial statements.
In November 2021, FASB issued ASU 2021-10 ASC Topic 832: Government Assistance (“Topic 832”): Disclosures by Business Entities about Government Assistance (“ASU 2021-10”), which expected to increase transparency in financial reporting by requiring business entities to disclose information about certain types of government assistance received. ASU 2021-10 is effective for financial statements issued for annual periods beginning after December 15, 2021 for all entities except not-for-profit entities and employee benefit plans within the scope of Topics 960, 962, and 965 on plan accounting. The Company has completed its assessment and concluded that ASU 2021-10 is applicable to the Company as the Company received government grants. The Company will make the necessary disclosures in the financial statements for Fiscal 2023.
In March 2020, FASB issued ASU 2020-04, updating ASC Topic 848: Reference Rate Reform (“Topic 848”): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued. ASU 2020-04 is effective for all entities as of March 12, 2020, and the Company may elect to apply ASU 2020-04 prospectively through December 31, 2022. The Company has completed its assessment and concluded that ASU 2020-04 has no significant impact to the Company’s consolidated financial statements.
In June 2016, FASB issued ASU 2016-13 ASC Topic 326, Financial Instruments — Credit Losses (“Topic 326”) (“ASU 2016-13”) for the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Topic 326 is effective for the Company for annual periods beginning after December 15, 2022. The Company has completed its assessment and concluded that ASU 2016-03 has no significant impact to the Company’s consolidated financial statements.
Other new pronouncements issued but not yet effective until after September 30, 2022, are not expected to have a significant effect on the Company’s consolidated financial position or results of operations.
3. TERM DEPOSITS
| Sept. 30, | June 30, | |||||||
| 2022 | 2022 | |||||||
| (Unaudited) | ||||||||
| Short-term deposits | $ | $ | ||||||
| Currency translation effect on short-term deposits | ( | ) | ( | ) | ||||
| Total short-term deposits | ||||||||
| Restricted term deposits | ||||||||
| Currency translation effect on restricted term deposits | ( | ) | ( | ) | ||||
| Total restricted term deposits | ||||||||
| Total term deposits | $ | $ | ||||||
Restricted deposits represent the amount of cash pledged to secure loans payable to financial institutions and serve as collateral for public utility agreements such as electricity and water, and performance bonds related to customs duty payable. Restricted deposits are classified as noncurrent assets, as they relate to long-term obligations and will become unrestricted only upon discharge of the obligations. Short-term deposits represent bank deposits, which do not qualify as cash equivalents.
4. TRADE ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
Accounts receivable are customer obligations due under normal trade terms. The Company performs continuing credit evaluations of its customers’ financial conditions, and although management generally does not require collateral, letters of credit may be required from the customers in certain circumstances.
Senior management reviews accounts receivable on a periodic basis to determine if any receivables will potentially be uncollectible. Management includes any accounts receivable balances that are determined to be uncollectible in the allowance for doubtful accounts. After all reasonable attempts to collect a receivable have failed, the receivable is written off against the allowance. Based on the information available, management believed the allowance for doubtful accounts as of September 30, 2022, and June 30, 2022, was adequate.
The following table represents the changes in the allowance for doubtful accounts:
| Sept. 30, | June 30, | |||||||
| 2022 | 2022 | |||||||
| (Unaudited) | ||||||||
| Beginning | $ | $ | ||||||
| Additions charged to expenses | ||||||||
| Recovered | ( | ) | ( | ) | ||||
| Currency translation effect | ( | ) | ( | ) | ||||
| Ending | $ | $ | ||||||
5. LOANS RECEIVABLE FROM PROPERTY DEVELOPMENT PROJECTS
The following table presents Trio-Tech (Chongqing) Co. Ltd (“TTCQ”)’s loan receivables from property development projects in China as of September 30, 2022.
| Loan Expiry | Loan Amount | Loan Amount | |||
| Date | (RMB) | (U.S. Dollars) | |||
| Short-term loan receivables |
| ||||
| JiangHuai (Project – Yu Jin Jiang An) | May 31, 2013 | | | ||
| Less: allowance for doubtful receivables |
|
| |||
| Net loan receivables from property development projects | - | - | |||
| Long-term loan receivables | |||||
| Jun Zhou Zhi Ye | Oct 31, 2016 | | | ||
| Less: transfer – down-payment for purchase of investment property |
|
| |||
| Net loan receivables from property development projects | - | - |
The short-term loan receivables amounting to renminbi (“RMB”) or approximately $
The loan amounting to RMB
6. INVENTORIES
Inventories consisted of the following:
| Sept. 30, 2022 | June 30, 2022 | |||||||
| (Unaudited) | ||||||||
| Raw materials | $ | $ | ||||||
| Work in progress | ||||||||
| Finished goods | ||||||||
| Less: provision for obsolete inventories | ( | ) | ( | ) | ||||
| Currency translation effect | ( | ) | ||||||
| $ | $ | |||||||
The following table represents the changes in provision for obsolete inventories:
| Sept. 30, 2022 | June 30, 2022 | |||||||
| (Unaudited) | ||||||||
| Beginning | $ | $ | ||||||
| Additions charged to expenses | ||||||||
| Usage – disposition | ( | ) | ( | ) | ||||
| Currency translation effect | ( | ) | ||||||
| Ending | $ | $ | ||||||
7. INVESTMENT PROPERTIES
The following table presents the Company’s investment in properties in China as of September 30, 2022. The exchange rate is based on the market rate as of September 30, 2022.
| Investment Date / Reclassification | Investment | Investment Amount | |||||||
| Date | Amount (RMB) | (U.S. Dollars) | |||||||
| Purchase of rental property – Property I – MaoYe Property | Jan 04, 2008 | ||||||||
| Currency translation | ( | ) | |||||||
| Reclassification as “Assets held for sale” | July 01, 2018 | ( | ) | ( | ) | ||||
| Reclassification from “Assets held for sale” | Mar 31, 2019 | ||||||||
| Purchase of rental property – Property II - JiangHuai | Jan 06, 2010 | ||||||||
| Purchase of rental property – Property III - FuLi | Apr 08, 2010 | ||||||||
| Currency translation | ( | ) | |||||||
| Gross investment in rental property | |||||||||
| Accumulated depreciation on rental property | Sep 30, 2022 | ( | ) | ( | ) | ||||
| Reclassified as “Assets held for sale”- MaoYe Property | July 01, 2018 | ||||||||
| Reclassification from “Assets held for sale”- MaoYe Property | Mar 31, 2019 | ( | ) | ( | ) | ||||
| ( | ) | ( | ) | ||||||
| Net investment in property – China | |||||||||
The following table presents the Company’s investment in properties in China as of June 30, 2022. The exchange rate is based on the market rate as of June 30, 2022.
| Investment Date / Reclassification | Investment | Investment Amount | ||||||||
| Date | Amount (RMB) | (U.S. Dollars) | ||||||||
| Purchase of rental property – Property I – MaoYe Property | Jan 04, 2008 | |||||||||
| Currency translation | ( | ) | ||||||||
| Reclassification as “Assets held for sale” | July 01, 2018 | ( | ) | ( | ) | |||||
| Reclassification from “Assets held for sale” | Mar 31, 2019 | |||||||||
| Purchase of rental property – Property II - JiangHuai | Jan 06, 2010 | |||||||||
| Purchase of rental property – Property III - FuLi | Apr 08, 2010 | |||||||||
| Currency translation | ( | ) | ||||||||
| Gross investment in rental property | ||||||||||
| Accumulated depreciation on rental property | Jun 30, 2022 | ( | ) | ( | ) | |||||
| Reclassified as “Assets held for sale”- MaoYe Property | July 01, 2018 | |||||||||
| Reclassification from “Assets held for sale”- MaoYe Property | Mar 31, 2019 | ( | ) | ( | ) | |||||
| ( | ) | ( | ) | |||||||
| Net investment in property – China | ||||||||||
Rental Property I - MaoYe Property
In the fiscal year ended June 30, 2008, TTCQ purchased an office in Chongqing, China from MaoYe Property Ltd. (“MaoYe”) for a total cash purchase price of RMB
Property purchased from MaoYe generated a rental income of $
Depreciation expense for MaoYe was $
Rental Property II - JiangHuai
During the year ended June 30, 2010 (“Fiscal 2010”), TTCQ purchased eight units of commercial property in Chongqing, China from Chongqing JiangHuai Real Estate Development Co. Ltd. (“JiangHuai”) for a total purchase price of RMB
Property purchased from JiangHuai did not generate any rental income for the three months ended September 30, 2022 and 2021.
Depreciation expense for JiangHuai was $
Rental Property III – FuLi
In Fiscal 2010, TTCQ entered into a Memorandum Agreement with Chongqing FuLi Real Estate Development Co. Ltd. (“FuLi”) to purchase commercial properties totaling
One of the commercial properties was leased from TTCQ by a third party under a -year lease to rent out the
TTCQ is actively searching for tenants to occupy the one commercial properties, which is vacant as of the date of this Report.
Properties purchased from FuLi generated a rental income of $
Depreciation expense for FuLi was $
Summary
Total rental income for all investment properties in China was $
Depreciation expenses for all investment properties in China were $
8. OTHER ASSETS
Other assets consisted of the following:
| Sept. 30, | June 30, | |||||||
| 2022 | 2022 | |||||||
| (Unaudited) | ||||||||
| Down payment for purchase of investment properties * | $ | $ | ||||||
| Down payment for purchase of property, plant and equipment | ||||||||
| Deposits for rental and utilities and others | ||||||||
| Currency translation effect | ( | ) | ( | ) | ||||
| Total | $ | $ | ||||||
*Down payment for purchase of investment properties included:
| 2022 | ||||||||
| RMB | U.S. Dollars | |||||||
| Original Investment (10% of Junzhou equity) | $ | $ | ||||||
| Less: Management Fee | ( | ) | ( | ) | ||||
| Net Investment | ||||||||
| Less: Share of Loss on Joint Venture | ( | ) | ( | ) | ||||
| Net Investment as Down Payment (Note *a) | ||||||||
| Loans Receivable | ||||||||
| Interest Receivable | ||||||||
| Less: Impairment of Interest | ( | ) | ( | ) | ||||
| Transferred to Down Payment (Note *b) | ||||||||
| * Down Payment for Purchase of Investment Properties | ||||||||
| Less: Effect of foreign currency exchange | - | ( | ) | |||||
| Less: Provision of Impairment loss on other assets | ( | ) | ( | ) | ||||
| * Down Payment for Purchase of Investment Properties | $ | - | $ | - | ||||
| a) | In Fiscal 2011, the Company signed a Joint Venture agreement (the “Agreement”) with Jia Sheng Property Development Co. Ltd. (the “Developer”) to form a new company, Junzhou Co. Limited (“Joint Venture” or “Junzhou”), to jointly develop the “Singapore Themed Park” project (the “Project”). The Company paid million for the
In Fiscal 2014, the Company disposed of its entire interest in the Joint Venture but, to date, has not received payment in full therefor. The Company recognized a disposal based on the recorded net book value of RMB |
| b) | Amounts of RMB
The shop lots are to be delivered to TTCQ upon completion of the construction of the shop lots in Singapore Themed Resort Project. The initial targeted date of completion was in the fiscal year ended June 30, 2017. However, the progress has been delayed as the developer is currently undergoing asset reorganization process, to re-negotiate with their creditors to complete the project.
During the fourth quarter of Fiscal 2021, the Company accrued an impairment charge of $ |
9. LINES OF CREDIT
Carrying value of the Company’s lines of credit approximates its fair value because the interest rates associated with the lines of credit are adjustable in accordance with market situations when the Company borrowed funds with similar terms and remaining maturities.
The Company’s credit rating provides it with ready and adequate access to funds in global markets.
As of September 30, 2022, the Company had certain lines of credit that are collateralized by restricted deposits.
| Entity with | Type of | Interest | Credit | Unused | ||||||
| Facility | Facility | Rate | Limitation | Credit | ||||||
| Trio-Tech International Pte. Ltd., Singapore |
|
| $ | | $ | | ||||
| Universal (Far East) Pte. Ltd. |
|
| $ | | $ | | ||||
| Trio-Tech Malaysia Sdn. Bhd. | Revolving credit |
| $ | | $ | | ||||
As of June 30, 2022, the Company had certain lines of credit that are collateralized by restricted deposits.
| Entity with | Type of | Interest | Credit | Unused | ||||||
| Facility | Facility | Rate | Limitation | Credit | ||||||
| Trio-Tech International Pte. Ltd., Singapore |
|
| $ | | $ | | ||||
| Universal (Far East) Pte. Ltd. |
|
| $ | | $ | | ||||
| Trio-Tech Malaysia Sdn. Bhd. | Revolving credit |
| $ | | $ | | ||||
10. ACCRUED EXPENSE
Accrued expense consisted of the following:
| Sept. 30, | June 30, | |||||||
| 2022 | 2022 | |||||||
| (Unaudited) | ||||||||
| Payroll and related costs | $ | $ | ||||||
| Commissions | ||||||||
| Customer deposits | ||||||||
| Legal and audit | ||||||||
| Sales tax | ||||||||
| Utilities | ||||||||
| Warranty | ||||||||
| Accrued purchase of materials and property, plant and equipment | ||||||||
| Provision for reinstatement | ||||||||
| Deferred income | ||||||||
| Contract liabilities | ||||||||
| Other accrued expense | ||||||||
| Currency translation effect | ( | ) | ||||||
| Total | $ | $ | ||||||
11. WARRANTY ACCRUAL
The Company provides for the estimated costs that may be incurred under its warranty program at the time the sale is recorded. The warranty period of the products manufactured by the Company is generally one year or the warranty period agreed upon with the customer. The Company estimates the warranty costs based on the historical rates of warranty returns. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amounts as necessary.
| Sept. 30, | June 30, | |||||||
| 2022 | 2022 | |||||||
| (Unaudited) | ||||||||
| Beginning | $ | $ | ||||||
| Additions charged to cost and expense | ||||||||
| Reversal | ( | ) | ( | ) | ||||
| Currency translation effect | ( | ) | ||||||
| Ending | $ | $ | ||||||
12. BANK LOANS PAYABLE
Bank loans payable consisted of the following:
| Sept. 30, | June 30, | |||||||
| 2022 | 2022 | |||||||
| (Unaudited) | ||||||||
| Note payable denominated in the Malaysian Ringgit for expansion plans in Malaysia, maturing in April 2028, bearing interest at the bank’s prime rate less ( and at September 30, 2022 and June 30, 2022) per annum, with monthly payments of principal plus interest through August 2028, collateralized by the acquired building with a carrying value of $ and $, as at September 30, 2022 and June 30, 2022, respectively. | $ | $ | ||||||
| Financing arrangement at fixed interest rate per annum, with monthly payments of principal plus interest through July 2025. | ||||||||
| Financing arrangement at fixed interest rate per annum, with monthly payments of principal plus interest through December 2026. | ||||||||
| Financing arrangement at fixed interest rate per annum, with monthly payments of principal plus interest through August 2027. | ||||||||
| Total bank loans payable | $ | $ | ||||||
| Current portion of bank loans payable | ||||||||
| Currency translation effect on current portion of bank loans | ( | ) | ( | ) | ||||
| Current portion of bank loans payable | ||||||||
| Long-term portion of bank loans payable | ||||||||
| Currency translation effect on long-term portion of bank loans | ( | ) | ( | ) | ||||
| Long-term portion of bank loans payable | $ | |||||||
Future minimum payments (excluding interest) as at September 30, 2022, were as follows:
| Remainder of Fiscal 2023 | $ | |||
| 2024 | ||||
| 2025 | ||||
| 2026 | ||||
| 2027 | ||||
| Thereafter | ||||
| Total obligations and commitments | $ |
Future minimum payments (excluding interest) as at June 30, 2022, were as follows:
| 2023 | $ | |||
| 2024 | ||||
| 2025 | ||||
| 2026 | ||||
| 2027 | ||||
| Thereafter | ||||
| Total obligations and commitments | $ |
13. COMMITMENTS AND CONTINGENCIES
The Company had capital commitments in China for the purchase of equipment and other related infrastructure costs amounting to or approximately $
The Company is, from time to time, the subject of litigation claims and assessments arising out of matters occurring in its normal business operations. In the opinion of management, resolution of these matters will not have a material adverse effect on the Company’s financial statements.
14. BUSINESS SEGMENTS
The Company operated in segments; the testing service industry (which performs structural and electronic tests of semiconductor devices), the designing and manufacturing of equipment (assembly of equipment that tests the structural integrity of integrated circuits and other products), distribution of various products from other manufacturers in Singapore and Asia and the real estate segment in China.
The cost of equipment, current year investment in new equipment and depreciation expense are allocated into respective segments based on primary purpose for which the equipment was acquired.
All intersegment sales were sales from the manufacturing segment to the testing and distribution segment. Total intersegment sales were $
The following segment Information is unaudited for the three months ended September 30, 2022, and September 30, 2021:
Business Segment Information:
| Three Months | |||||||||||||||||||||
| Ended | Net | Operating | Total | Depr. And | Capital | ||||||||||||||||
| Sept. 30, | Revenue | Income / (Loss) | Assets | Amort. | Expenditures | ||||||||||||||||
| Manufacturing | 2022 | $ | $ | $ | $ | $ | |||||||||||||||
| 2021 | $ | $ | $ | $ | $ | ||||||||||||||||
| Testing Services | 2022 | ||||||||||||||||||||
| 2021 | |||||||||||||||||||||
| Distribution | 2022 | ||||||||||||||||||||
| 2021 | |||||||||||||||||||||
| Real Estate | 2022 | ( | ) | ||||||||||||||||||
| 2021 | ( | ) | |||||||||||||||||||
| Corporate & Unallocated | 2022 | ( | ) | ||||||||||||||||||
| 2021 | ( | ) | |||||||||||||||||||
| Total Company | 2022 | $ | $ | $ | $ | $ | |||||||||||||||
| 2021 | $ | $ | $ | $ | $ | ||||||||||||||||
15. OTHER INCOME
Other income consisted of the following:
| Three Months Ended | ||||||||
| September 30, | ||||||||
| 2022 | 2021 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Interest income | $ | $ | ||||||
| Other rental income | ||||||||
| Exchange gain | ||||||||
| Bad debt recovery | ||||||||
| Government grant | ||||||||
| Other miscellaneous income | ||||||||
| Total | $ | $ | ||||||
16. INCOME TAX
The Company is subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgment is required in determining the provision for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws. The statute of limitations, in general, is open for years 2016 to 2022 for tax authorities in those jurisdictions to audit or examine income tax returns. The Company is under annual review by the tax authorities of the respective jurisdiction to which the subsidiaries belong.
Due to the enactment of the Tax Act, the Company is subject to a tax on global intangible low-taxed income (“GILTI”). GILTI is a tax on foreign income in excess of a deemed return on tangible assets of foreign corporations. Companies subject to GILTI have the option to account for the GILTI tax as a period cost if and when incurred, or to recognize deferred taxes for temporary differences including outside basis differences expected to reverse as GILTI. The Company has elected to account for GILTI as a period cost. GILTI expense was $
The Company's income tax expense was $
| 1. | The Singapore operations incurred higher income tax due to higher income generated in period ended September 30,2022 compared to same period last fiscal year. |
| 2. | The Company recognizing higher GILTI expenses due to higher income derived from controlled foreign corporation |
The Company accrues penalties and interest related to unrecognized tax benefits when necessary as a component of penalties and interest expense, respectively. The Company had
In assessing the ability to realize the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on these criteria, management believes it is more likely than not the Company will not realize the benefits of the federal, state, and foreign deductible differences. Accordingly, a valuation allowance has been established against deferred tax assets recorded in the U.S. and various foreign jurisdictions.
17. REVENUE
The Company generates revenue primarily from 3 different segments: Manufacturing, Testing and Distribution. The Company accounts for a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. The Company’s revenues are measured based on consideration stipulated in the arrangement with each customer, net of any sales incentives and amounts collected on behalf of third parties, such as sales taxes. The revenues are recognized as separate performance obligations that are satisfied by transferring control of the product or service to the customer.
Significant Judgments
The Company’s arrangements with its customers include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. A product or service is considered distinct if it is separately identifiable from other deliverables in the arrangement and if a customer can benefit from it on its own or with other resources that are readily available to the customer.
The Company allocates the transaction price to each performance obligation on a relative standalone selling price basis (“SSP”). Determining the SSP for each distinct performance obligation and allocation of consideration from an arrangement to the individual performance obligations and the appropriate timing of revenue recognition are significant judgments with respect to these arrangements. The Company typically establishes the SSP based on observable prices of products or services sold separately in comparable circumstances to similar clients. The Company may estimate SSP by considering internal costs, profit objectives and pricing practices in certain circumstances.
Warranties, discounts and allowances are estimated using historical and recent data trends. The Company includes estimates in the transaction price only to the extent that a significant reversal of revenue is not probable in subsequent periods. The Company’s products and services are generally not sold with a right of return, nor has the Company experienced significant returns from or refunds to its customers.
Manufacturing
The Company primarily derives revenue from the sale of both front-end and back-end semiconductor test equipment and related peripherals, maintenance and support of all these products, installation and training services and the sale of spare parts. The Company’s revenues are measured based on consideration stipulated in the arrangement with each customer, net of any sales incentives and amounts collected on behalf of third parties, such as sales taxes.
The Company recognizes revenue at a point in time when the Company has satisfied its performance obligation by transferring control of the product to the customer. The Company uses judgment to evaluate whether the control has transferred by considering several indicators, including:
| ● | whether the Company has a present right to payment; |
| ● | the customer has legal title; |
| ● | the customer has physical possession; |
| ● | the customer has significant risk and rewards of ownership; and |
| ● | the customer has accepted the product, or whether customer acceptance is considered a formality based on history of acceptance of similar products (for example, when the customer has previously accepted the same equipment, with the same specifications, and when we can objectively demonstrate that the tool meets all the required acceptance criteria, and when the installation of the system is deemed perfunctory). |
Not all indicators need to be met for the Company to conclude that control has transferred to the customer. In circumstances in which revenue is recognized prior to the product acceptance, the portion of revenue associated with its performance obligations of product installation and training services are deferred and recognized upon acceptance.
The majority of sales under the Manufacturing segment include a standard 12-month warranty which are mainly assurance warranty and are not separate performance obligations. Warranty provided for some customized products may be classified as service warranties and are separate performance obligations. Transaction prices are allocated to this performance obligation using cost plus method. The portion of revenue associated with warranty service is deferred and recognized as revenue over the warranty period, as the customer simultaneously receives and consumes the benefits of warranty services provided by the Company.
Testing
The Company renders testing services to manufacturers and purchasers of semiconductors and other entities who either lack testing capabilities or whose in-house screening facilities are insufficient. The Company primarily derives testing revenue from burn-in services, manpower supply and other associated services. SSP is directly observable from the sales orders. Revenue is allocated to performance obligations satisfied at a point in time depending upon terms of the sales order. Generally, there is no other performance obligation other than what has been stated inside the sales order for each of these sales.
Terms of contract that may indicate potential variable consideration include warranty, late delivery penalty and reimbursement to solve nonconformance issues for rejected products. Based on historical and recent data trends, it is concluded that these terms of the contract do not represent potential variable consideration. The transaction price is not contingent on the occurrence of any future event.
Distribution
The Company distributes complementary products, particularly equipment, industrial products and components by manufacturers mainly from the U.S., Europe and Taiwan. The Company recognizes revenue from product sales at a point in time when the Company has satisfied its performance obligation by transferring control of the product to the customer. The Company uses judgment to evaluate whether control has transferred by considering several indicators discussed above. The Company recognizes the revenue at a point in time, generally upon shipment or delivery of the products to the customer or distributors, depending upon terms of the sales order.
Contract Balances
The timing of revenue recognition, billings and collections may result in billed accounts receivable, unbilled receivables, contract assets, customer advances, deposits and contract liabilities. The Company’s payment terms and conditions vary by contract type, although terms generally include a requirement of payment of 70% to 90% of total contract consideration within 30 to 60 days of shipment with the remainder payable within 30 days of acceptance. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that its contracts generally do not include a significant financing component.
The following table is the reconciliation of contract balances.
| Sept. 30 | June 30 | |||||||
| 2022 | 2022 | |||||||
| (Unaudited) | ||||||||
| Trade Accounts Receivable | ||||||||
| Accounts Payable | ||||||||
| Contract Liabilities | ||||||||
Remaining Performance Obligation
As at September 30, 2022, the Company had $
As at June 30, 2022, the Company had $
Refer to Note 4 “Business Segments” of the Notes to Condensed Consolidated Financial Statements for information related to revenue.
18. EARNINGS PER SHARE
Options to purchase
Options to purchase
The following table is a reconciliation of the weighted average shares used in the computation of basic and diluted EPS for the period presented herein:
| Three Months Ended | ||||||||
| September 30, | ||||||||
| 2022 | 2021 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Income attributable to Trio-Tech International common shareholders from continuing operations, net of tax | $ | $ | ||||||
| Income attributable to Trio-Tech International common shareholders from discontinued operations, net of tax | ||||||||
| Net Income attributable to Trio-Tech International common shareholders | $ | $ | ||||||
| Weighted average number of common shares outstanding – basic | ||||||||
| Dilutive effect of stock options | ||||||||
| Number of shares used to compute earnings per share – diluted | ||||||||
| Basic earnings per share from continuing operations attributable to Trio-Tech International | ||||||||
| Basic earnings per share from discontinued operations attributable to Trio-Tech International | ||||||||
| Basic earnings per share from net income attributable to Trio-Tech International | $ | $ | ||||||
| Diluted earnings per share from continuing operations attributable to Trio-Tech International | ||||||||
| Diluted earnings per share from discontinued operations attributable to Trio-Tech International | ||||||||
| Diluted earnings per share from net income attributable to Trio-Tech International | $ | $ | ||||||
19. STOCK OPTIONS
On September 24, 2007, the Company’s Board of Directors unanimously adopted the 2007 Employee Stock Option Plan (the “2007 Employee Plan”) and the 2007 Directors Equity Incentive Plan (the “2007 Directors Plan” and, together with the 2007 Employee Plan, the “2007 Plans”), each of which was approved by the shareholders on December 3, 2007. Each of the 2007 Plans were amended during the term of such plan to increase the number of shares covered thereby. Each of the 2007 Plans terminated by their respective terms on September 24, 2017.
On September 14, 2017, the Company’s Board of Directors unanimously adopted the 2017 Employee Stock Option Plan (the “2017 Employee Plan”) and the 2017 Directors Equity Incentive Plan (the “2017 Directors Plan”) each of which was approved by the shareholders on December 4, 2017.
Assumptions
The fair value for the stock options granted to both employees and directors was estimated using the Black-Scholes option pricing model with the following weighted average assumptions, assuming:
| ● | An expected life varying from |
| ● | A risk-free interest rate varying from |
| ● | |
| ● | expected volatility of |
2017 Employee Stock Option Plan
The Company’s 2017 Employee Plan permits the grant of stock options to its employees covering up to an aggregate of
During the first quarter of Fiscal 2023,
During the first quarter of Fiscal 2022, the Company did grant any options pursuant to the 2017 Employee Plan. There were stock options exercised during the three-month period ended September 30, 2021. The Company recognized $
As of September 30, 2022, there were vested stock options granted under the 2017 Employee Plan covering a total of
As of September 30, 2021, there were vested stock options granted under the 2017 Employee Plan covering a total of
A summary of option activities under the 2017 Employee Plan during the three months period ended September 30, 2022, is presented as follows:
| Weighted | Weighted Average Remaining | Aggregate | ||||||||||||||
| Average | Contractual | Intrinsic | ||||||||||||||
| Options | Exercise Price | Term (Years) | Value | |||||||||||||
| Outstanding at July 1, 2022 | $ | $ | ||||||||||||||
| Granted | - | - | ||||||||||||||
| Exercised | ( | ) | - | - | ||||||||||||
| Forfeited or expired | ( | ) | - | - | - | |||||||||||
| Outstanding at September 30, 2022 | $ | $ | $ | |||||||||||||
| Exercisable at September 30, 2022 | $ | $ | $ | |||||||||||||
A summary of the status of the Company’s non-vested employee stock options during the three months ended September 30, 2022, is presented below:
|
| Weighted Average | |||||||
| Options | Grant-Date Fair Value | |||||||
| Non-vested at July 1, 2022 | $ | |||||||
| Granted | ||||||||
| Vested | ( | ) | - | |||||
| Non-vested at September 30, 2022 | $ | |||||||
A summary of option activities under the 2017 Employee Plan during the three months period ended September 30, 2021, is presented as follows:
| Weighted | Weighted Average Remaining | Aggregate | ||||||||||||||
| Average | Contractual | Intrinsic | ||||||||||||||
| Options | Exercise Price | Term (Years) | Value | |||||||||||||
| Outstanding at July 1, 2021 | $ | $ | ||||||||||||||
| Granted | - | - | - | - | ||||||||||||
| Exercised | - | - | - | - | ||||||||||||
| Forfeited or expired | - | - | - | - | ||||||||||||
| Outstanding at September 30, 2021 | $ | $ | $ | |||||||||||||
| Exercisable at September 30, 2021 | $ | $ | $ | |||||||||||||
A summary of the status of the Company’s non-vested employee stock options during the three months period ended September 30, 2021, is presented below:
|
| Weighted Average | |||||||
| Options | Grant-Date Fair Value | |||||||
| Non-vested at July 1, 2021 | $ | |||||||
| Granted | - | - | ||||||
| Vested | - | - | ||||||
| Forfeited | - | - | ||||||
| Non-vested at September 30, 2021 | $ | |||||||
2007 Employee Stock Option Plan
The Company’s 2007 Employee Plan permitted the issuance of options to employees. As of the last amendment thereof, the 2007 Employee Plan covered an aggregate of
There were
As of July 1, 2022 and September 30, 2022, there were
As of September 30, 2021, there were vested stock options granted under the 2007 Employee Plan covering a total of
A summary of option activities under the 2007 Employee Plan during the three months ended September 30 2021, is presented as follows:
| Weighted | Weighted Average Remaining | Aggregate | ||||||||||||||
| Average | Contractual | Intrinsic | ||||||||||||||
| Options | Exercise Price | Term (Years) | Value | |||||||||||||
| Outstanding at July 1, 2021 | $ | $ | ||||||||||||||
| Granted | - | - | - | - | ||||||||||||
| Exercised | - | - | - | - | ||||||||||||
| Forfeited or expired | - | - | - | - | ||||||||||||
| Outstanding at September 30, 2021 | $ | $ | $ | |||||||||||||
| Exercisable at September 30, 2021 | $ | $ | $ | |||||||||||||
There were
2017 Directors Equity Incentive Plan
The 2017 Directors Plan initially covered an aggregate of
During the first quarter of Fiscal 2023 and Fiscal 2022, the Company did grant any options pursuant to the 2017 Directors Plan. There were
As all the stock options granted under the 2017 Directors Plan vest immediately on the date of grant, there were
As of September 30, 2022, there were vested stock options granted under the 2017 Directors Plan covering a total of
As of September 30, 2021, there were vested stock options granted under the 2017 Directors Plan covering a total of
A summary of option activities under the 2017 Directors Plan during the three months ended September 30, 2022, is presented as follows:
| Weighted | Weighted Average Remaining | Aggregate | ||||||||||||||
| Average | Contractual | Intrinsic | ||||||||||||||
| Options | Exercise Price | Term (Years) | Value | |||||||||||||
| Outstanding at July 1, 2022 | $ | $ | ||||||||||||||
| Granted | - | - | - | |||||||||||||
| Exercised | - | - | - | - | ||||||||||||
| Forfeited or expired | - | - | - | - | ||||||||||||
| Outstanding at September 30, 2022 | $ | $ | $ | |||||||||||||
| Exercisable at September 30, 2022 | $ | $ | $ | |||||||||||||
A summary of option activities under the 2017 Directors Plan during the three months ended September 30, 2021, is presented as follows:
| Weighted | Weighted Average Remaining | Aggregate | ||||||||||||||
| Average | Contractual | Intrinsic | ||||||||||||||
| Options | Exercise Price | Term (Years) | Value | |||||||||||||
| Outstanding at July 1, 2021 | $ | $ | ||||||||||||||
| Granted | - | - | - | - | ||||||||||||
| Exercised | - | - | - | - | ||||||||||||
| Forfeited or expired | - | - | - | - | ||||||||||||
| Outstanding at September 30, 2022 | $ | $ | $ | |||||||||||||
| Exercisable at September 30, 2022 | $ | $ | $ | |||||||||||||
2007 Directors Equity Incentive Plan
The Company’s 2007 Directors Plan permitted the grant of stock options to its directors in the form of nonqualified options and restricted stock. As of the last amendment thereof, the 2007 Directors Plan covered an aggregate of
There were
As of July 1, 2022 and September 30, 2022, there were
As of September 30, 2022, there were
As of September 30, 2021, there were vested stock options granted under the 2007 Directors Plan covering a total of
A summary of option activities under the 2007 Directors Plan during the three months ended September 30, 2021 is presented as follows:
| Weighted | Weighted Average Remaining | Aggregate | ||||||||||||||
| Average | Contractual | Intrinsic | ||||||||||||||
| Options | Exercise Price | Term (Years) | Value | |||||||||||||
| Outstanding at July 1, 2021 | $ | $ | ||||||||||||||
| Granted | - | - | - | - | ||||||||||||
| Exercised | - | - | ||||||||||||||
| Forfeited or expired | - | - | ||||||||||||||
| Outstanding at September 30, 2021 | $ | $ | 0.49 | $ | ||||||||||||
| Exercisable at September 30, 2021 | $ | $ | 0.49 | $ | ||||||||||||
20. LEASES
Company as Lessor
Operating leases under which the Company is the lessor arise from leasing the Company’s commercial real estate investment property to third parties. Initial lease terms generally range from
Future minimum rental income in China and Thailand to be received from Fiscal 2023 to the fiscal year ended June 30, 2027 (“Fiscal 2027”) on noncancelable operating leases is contractually due as follows as of September 30, 2022:
| Remainder of fiscal 2023 | $ | |||
| Fiscal 2024 | ||||
| Fiscal 2025 | ||||
| Fiscal 2026 | ||||
| Fiscal 2027 | ||||
| $ |
Future minimum rental income in China and Thailand to be received from Fiscal 2023 to Fiscal 2024 on non-cancelable operating leases is contractually due as follows as of June 30, 2022:
| 2023 | $ | |||
| 2024 | $ | |||
| 2025 | $ | |||
| 2026 | $ | |||
| 2027 | $ | |||
| $ |
Sales-type leases under which the Company is the lessor arise from the lease of units of chiller systems. The Company classifies its lease arrangements at inception of the arrangement. The lease term is years, contains an automatic transfer of title at the end of the lease term and a guarantee of residual value at the end of the lease term. The customer is required to pay for executory costs such as taxes.
Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales of units of chiller systems are as follows:
| Components of Lease Balances | Sept. 30, | |||
| 2022 | ||||
| Assets | ||||
| Gross financial sales receivable | $ | |||
| Unearned finance income | ( | ) | ||
| Financed sales receivable | $ | |||
| Net financed sales receivables due within one year | $ | |||
| Net financed sales receivables due after one year | $ | |||
As of September 30, 2022, the financed sale receivables had a weighted average effective interest rate of
Company as Lessee
The Company is the lessee under operating leases for corporate offices and research and development facilities with remaining lease terms of year to years and finance leases for plant and equipment.
Supplemental balance sheet information related to leases was as follows (in thousands):
| Sept. 30, | June 30, | |||||||
| 2022 | 2022 | |||||||
| (Unaudited) | ||||||||
| Finance Leases (Plant and Equipment) | ||||||||
| Plant and equipment, at cost | $ | $ | ||||||
| Accumulated depreciation | ( | ) | ( | ) | ||||
| Plant and Equipment, Net | $ | $ | ||||||
| Current portion of finance leases | $ | $ | ||||||
| Net of current portion of finance leases | ||||||||
| Total Finance Lease Liabilities | $ | $ | ||||||
| Operating Leases (Corporate Offices, Research and Development Facilities) | ||||||||
| Operating lease right-of-use assets | $ | $ | ||||||
| Operating lease right-of-use assets, Net | $ | 2,759 | $ | 3,152 | ||||
| Current portion of operating leases | ||||||||
| Net of current portion of operating leases | ||||||||
| Total Operating Lease Liabilities | $ | $ | ||||||
| Three Months Ended | ||||||||
| Sept. 30, | Sept. 30, | |||||||
| 2022 | 2021 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Lease Cost | ||||||||
| Finance lease cost: | ||||||||
| Interest on finance lease | $ | $ | ||||||
| Amortization of right-of-use assets | ||||||||
| Total finance lease cost | ||||||||
| Operating lease cost | $ | $ | ||||||
Other information related to leases was as follows (in thousands except lease term and discount rate):
| Three Months Ended | ||||||||
| Sept. 30, | Sept. 30, | |||||||
| 2022 | 2021 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Cash Paid for Amounts Included in the Measurement of Lease Liabilities | ||||||||
| Operating cash flows from finance leases | $ | ( | ) | $ | ( | ) | ||
| Operating cash flows from operating leases | ( | ) | ( | ) | ||||
| Finance cash flows from finance leases | ( | ) | ( | ) | ||||
| Right-of-Use Assets Obtained in Exchange for New Operating Lease Liabilities | ||||||||
| Weighted-Average Remaining Lease Term: | ||||||||
| Finance leases | ||||||||
| Operating leases | ||||||||
| Weighted-Average Discount Rate: | ||||||||
| Finance leases | % | % | ||||||
| Operating leases | % | % | ||||||
As of September 30, 2022, the maturities of the Company’s operating and finance lease liabilities are as follow:
| Operating Lease Liabilities | Finance Lease Liabilities | |||||||
| Fiscal Year | ||||||||
| Remainder of Fiscal 2023 | ||||||||
| 2024 | ||||||||
| 2025 | ||||||||
| 2026 | ||||||||
| Thereafter | ||||||||
| Total future minimum lease payments | ||||||||
| Less: amount representing interest | ( | ) | ( | ) | ||||
| Present value of net minimum lease payments | ||||||||
| Presentation on statement of financial position | ||||||||
| Current | ||||||||
| Non-Current | ||||||||
As of June 30, 2022, future minimum lease payments under finance leases and noncancelable operating leases were as follows:
| Operating Lease Liabilities | Finance Lease Liabilities | |||||||
| Fiscal Year | ||||||||
| 2023 | ||||||||
| 2024 | ||||||||
| 2025 | ||||||||
| 2026 | ||||||||
| Thereafter | ||||||||
| Total future minimum lease payments | ||||||||
| Less: amount representing interest | ( | ) | ( | ) | ||||
| Present value of net minimum lease payments | ||||||||
| Presentation on statement of financial position | ||||||||
| Current | ||||||||
| Non-Current | ||||||||
21. FAIR VALUE OF FINANCIAL INSTRUMENTS APPROXIMATE CARRYING VALUE
In accordance with ASC Topics 825 and 820, the following presents assets and liabilities measured and carried at fair value and classified by level of fair value measurement hierarchy:
There were no transfers between Levels 1 and 2 during the three months ended September 30, 2022 and 2021.
Term deposits (Level 2) – The carrying amount approximates fair value because of the short maturity of these instruments.
Restricted term deposits (Level 2) – The carrying amount approximates fair value because of the short maturity of these instruments.
Lines of credit (Level 3) – The carrying value of the lines of credit approximates fair value due to the short-term nature of the obligations.
Bank loans payable (Level 3) – The carrying value of the Company’s bank loans payable approximates its fair value as the interest rates associated with long-term debt is adjustable in accordance with market situations when the Company borrowed funds with similar terms and remaining maturities.
22. CONCENTRATION OF CUSTOMERS
The Company had
| For the Period Ended Sept. 30, | ||||||||
| 2022 | 2021 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Revenue | ||||||||
| - Customer A | % | % | ||||||
| - Customer B | % | % | ||||||
| Trade Account Receivables | ||||||||
| - Customer A | % | % | ||||||
| - Customer B | % | % | ||||||
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
Overview
The following should be read in conjunction with the condensed consolidated financial statements and notes in Item I above and with the audited consolidated financial statements and notes, the information under the headings “Management’s discussion and analysis of financial condition and results of operations” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.
Trio-Tech International (“TTI”) was incorporated in 1958 under the laws of the State of California. As used herein, the term “Trio-Tech” or “Company” or “we” or “us” or “Registrant” includes Trio-Tech International and its subsidiaries unless the context otherwise indicates. Our mailing address and executive offices are located at Block 1008 Toa Payoh North, Unit 03-09 Singapore 318996, and our telephone number is (65) 6265 3300.
The Company is a provider of reliability test equipment and services to the semiconductor industry. Our customers rely on us to verify that their semiconductor components meet or exceed the rigorous reliability standards demanded for aerospace, communications and other electronics products.
During the three months ended September 30, 2022, TTI generated approximately 99.9% of its revenue from its three core business segments in the test and measurement industry, i.e., manufacturing of test equipment, testing services and distribution of test equipment. The Real Estate segment contributed only 0.01% to the total revenue during the three months ended September 30, 2022.
Manufacturing
TTI develops and manufactures an extensive range of test equipment used in the “front-end” and the “back-end” manufacturing processes of semiconductors. Our equipment includes leak detectors, autoclaves, centrifuges, burn-in systems and boards, HAST testers, temperature-controlled chucks, wet benches and more.
Testing
TTI provides comprehensive electrical, environmental, and burn-in testing services to semiconductor manufacturers in our testing laboratories in Asia and the United States (“U.S.”). Our customers include both manufacturers and end users of semiconductor and electronic components who look to us when they do not want to establish their own facilities. The independent tests are performed to industry and customer specific standards.
Distribution
In addition to marketing our proprietary products, we distribute complementary products made by manufacturers mainly from the U.S., Europe, and Taiwan. The products include environmental chambers, handlers, interface systems, vibration systems, shaker systems, solderability testers and other semiconductor equipment. Besides equipment, we also distribute a wide range of components such as connectors, sockets, LCD display panels and touch screen panels. Furthermore, our range of products are mainly targeted for industrial products rather than consumer products whereby the life cycle of the industrial products can last from three years to seven years.
Real Estate
Our real estate segment generates investment income from the investments made and rental revenue received from real estate that we purchased in Chongqing, China.
Critical Accounting Estimates & Policies
The preparation of our Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions in applying our accounting policies that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base these estimates and assumptions on historical experience and evaluate them on an ongoing basis to ensure that they remain reasonable under current conditions. Actual results could differ from those estimates. We discuss the development and selection of the critical accounting estimates with the Audit Committee of our Board of Directors on a quarterly basis, and the Audit Committee has reviewed our related disclosure in this Quarterly Report on Form 10-Q.
There have been no material changes in our critical accounting estimates and policies since our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Refer to Note 1 “Basis of Presentation And Summary of significant Accounting Policies” to our Condensed Consolidated Financial Statements for additional details. In addition, please refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in Part II, Item 7 of our Annual Report on Form 10-K for our fiscal year ended June 30, 2022 for a complete description of our critical accounting policies and estimates.
First Quarter Fiscal Year 2023 Highlights
| ● |
Total revenue increased by $1,768, or 17.4%, to $11,939 in the first quarter of Fiscal 2023, compared to $10,171 for the same period in the fiscal year ended June 30, 2022 (“Fiscal 2022”). |
| ● |
Manufacturing segment revenue increased by $23, or 0.6% to $3,585 for the first quarter of Fiscal 2023, compared to $3,562 for the same period in Fiscal 2022. |
| ● |
Testing segment revenue increased by $1,764, or 38.3%, to $6,364 for the first quarter of Fiscal 2023, compared to $4,600 for the same period in Fiscal 2022. |
| ● |
Distribution segment revenue decreased by $16, or 0.0%, to $1,982 for the first quarter of Fiscal 2023, compared to $1,998 for the same period in Fiscal 2022. |
| ● |
Real estate segment rental revenue decreased by $3, or 27.3% to $8 for the first quarter of Fiscal 2023, compared to $11 for the same period in Fiscal 2022. |
| ● |
The overall gross profit margin decreased by 0.9% to 30.3% for the first quarter of Fiscal 2023, from 31.2% for the same period in Fiscal 2022. |
| ● |
General and administrative expense increased by $325, or 16.4%, to $2,305 for the first quarter of Fiscal 2023, from $1,980 for the same period in Fiscal 2022. |
| ● |
Selling expense increased by $26, or 17.7%, to $173 for the first quarter of Fiscal 2023, from $147 for the same period in Fiscal 2022. |
| ● |
Other income increased by $18, or 11.2%, to $179 for the first quarter of Fiscal 2023, from $161 for the same period in Fiscal 2022. |
| ● |
Income from operations was $1,067 for the first quarter of Fiscal 2023, an increase of $97 as compared to $970 for the same period in Fiscal 2022. |
| ● |
Income tax expense was $225 in the first quarter of Fiscal 2023, an increase of $45 as compared to $180 in the same period in Fiscal 2022. |
| ● |
During the first quarter of Fiscal 2023, income from continuing operations before non-controlling interest, net of tax was $977, as compared to income from continuing operations before non-controlling interest of $923 for the same period in Fiscal 2022. |
| ● |
Net income attributable to non-controlling interest for the first quarter of Fiscal 2023 was $96, an improvement of $85 as compared to $11 in the same period in Fiscal 2022. |
| ● |
Basic earnings per share for the first quarter of Fiscal 2023 was $0.22, as compared to earnings per share of $0.23 for the same period in Fiscal 2022. |
| ● |
Diluted earnings per share for the first quarter of Fiscal 2023 was $0.21, as compared to earnings per share of $0.23 for the same period in Fiscal 2022. |
| ● |
Total assets increased by $384 to $43,805 as of September 30, 2022, compared to $43,421 as of June 30, 2022. |
| ● |
Total liabilities increased by $568 to $15,987 as of September 30, 2022, compared to $15,419 as of June 30, 2022. |
Results of Operations and Business Outlook
The following table sets forth our revenue components for three months ended September 30, 2022 and 2021.
| Revenue Components |
Three Months Ended |
|||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| Manufacturing |
30.0 | % | 35.0 | % | ||||
| Testing Services |
53.3 | % | 45.2 | % | ||||
| Distribution |
16.6 | % | 19.6 | % | ||||
| Real Estate |
0.1 | % | 0.1 | % | ||||
| Total |
100.0 | % | 100.0 | % | ||||
Revenue for the three months ended September 30, 2022, was $11,939, an increase of $1,768 from $10,171, when compared to the revenue for the same period of the prior fiscal year. As a percentage, revenue increased by 17.4% for the three months ended September 30, 2022, when compared to revenue for the same period of the prior year.
For the three months ended September 30, 2022, there was an increase in revenue in Testing segment when compared to the same period of the prior fiscal year. Manufacturing and Distribution segments revenue remained almost at the same level as the same period of prior year.
Total revenue into and within China, the Southeast Asia regions and other countries (except revenue into and within the United States) increased by $1,774, or 18.3%, to $11,446 for the three months ended September 30, 2022, as compared with $9,672 for the same period of Fiscal 2022.
Total revenue into and within the U.S. was $493 for the three months ended September 30, 2022, a decrease of $6 from $499 for the same period of the prior year.
Revenue within our four current segments for the three months ended September 30, 2022, is discussed below.
Manufacturing Segment
Revenue in the manufacturing segment as a percentage of total revenue was 30.0% for the three months ended September 30, 2022, a decrease of 5% of total revenue when compared to 35.0% in the same period of Fiscal 2022. The absolute amount of revenue increased by $23 to $3,585 for the three months ended September 30, 2022, compared to $3,562, for the same period of Fiscal 2022.
Testing Services Segment
The testing segment's revenue was 53.3% for the three months ended September 30, 2022, representing an increase of 8.1%, compared to 45.2% for the same period of Fiscal 2022. The absolute amount of revenue increased by $1,764 to $6,364 from $4,600 for the three months ended September 30, 2022, as compared to the same period of Fiscal 2022.
During the third quarter of Fiscal 2022, the Company incorporated Trio-Tech (Jiangsu) Co. Ltd. (“TTJS”), located in Suzhou, China together with Suzhou Anchuang Technology Management L.L.P. (“SATM”) to provide subcontract services in the semiconductor and/or other related services in the electronics industry, mainly in Suzhou, China. The joint venture contributed 22% of revenue in the testing segment for the three months ended September 30, 2022.
The revenue in the testing segment from one customer accounted for 30.8% and 40.4% of our revenue in the testing segment for the three months ended September 30, 2022 and 2021, respectively. The future revenue in the testing segment will be affected by the demands of this customer if the customer base cannot be increased. Demand for testing services varies from country to country, depending on any changes taking place in the market and our customers’ forecasts. As it is challenging to forecast fluctuations in the market accurately, management believes it is necessary to maintain testing facilities in close proximity to the customers in order to make it convenient for them to send us their newly manufactured parts for testing and to enable us to maintain a share of the market.
Distribution Segment
Revenue in the distribution segment was 16.6% as a percentage of total revenue for the three months ended September 30, 2022, a decrease of 3%, compared to the same period of Fiscal 2022. The absolute amount of revenue decreased by $16 to $1,982 from $1,998 for the three months ended September 30, 2022, compared to the same period of Fiscal 2022.
Demand for the distribution segment varies depending on the demand for our customers’ products, the changes taking place in the market, and our customers’ forecasts. Hence it is difficult to forecast fluctuations in the market accurately.
Real Estate Segment
The real estate segment accounted for 0.1% of total revenue for the three months ended September 30, 2022. The absolute amount of revenue decreased by $3 to $8 from $11 and remained comparable for the three months ended September 30, 2022, compared to the same period of Fiscal 2022.
Uncertainties and Remedies
There are several influencing factors which create uncertainties when forecasting performance, such as the constantly changing nature of technology, specific requirements from the customer, decline in demand for certain types of burn-in devices or equipment, decline in demand for testing services and fabrication services, and other similar factors. One factor that influences uncertainty is the highly competitive nature of the semiconductor industry. Another is that some customers are unable to provide a forecast of the products required in the upcoming weeks; hence it is difficult to plan for the resources needed to meet these customers’ requirements due to short lead time and last-minute order confirmation. This will normally result in a lower margin for these products as it is more expensive to purchase materials in a short time frame. However, the Company has taken certain actions and formulated certain plans to deal with and to help mitigate these unpredictable factors. For example, in order to meet manufacturing customers’ demands upon short notice, the Company maintains higher inventories but continues to work closely with its customers to avoid stockpiling. We believe that we have improved customer service through our efforts to keep our staff up to date on the newest technology and stressing the importance of understanding and meeting the stringent requirements of our customers. Finally, the Company is exploring new markets and products, looking for new customers, and upgrading and improving burn-in technology while at the same time searching for improved testing methods for higher technology chips.
The Company’s primary exposure to movements in foreign currency exchange rates relates to non-U.S. dollar-denominated sales and operating expense in its subsidiaries. Strengthening of the U.S. dollar relative to foreign currencies adversely affects the U.S. dollar value of the Company’s foreign currency-denominated sales and earnings, and generally leads the Company to raise international pricing, potentially reducing demand for the Company’s products. Margins on sales of the Company’s products in foreign countries and on sales of products that include components obtained from foreign suppliers could be materially adversely affected by foreign currency exchange rate fluctuations. In some circumstances, for competitive or other reasons, the Company may decide not to raise local prices to fully offset the dollar’s strengthening, or at all, which would adversely affect the U.S. dollar value of the Company’s foreign currency-denominated sales and earnings. Conversely, a strengthening of foreign currencies relative to the U.S. dollar, while generally beneficial to the Company’s foreign currency denominated sales and earnings, could cause the Company to reduce international pricing, thereby limiting the benefit. Additionally, strengthening of foreign currencies may also increase the Company’s cost of product components denominated in those currencies, thus adversely affecting gross margins.
In December 2019, COVID-19 was reported to have surfaced in China, resulting in shutdowns of manufacturing and commerce in the months that followed. Since then, the COVID-19 pandemic has spread to multiple countries worldwide and has resulted in authorities implementing numerous measures to try to contain the disease and slow its spread, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. These measures have created significant uncertainty and economic disruption, both short-term and potentially long-term.
The degree to which COVID-19 impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including but not limited to the duration and spread of the pandemic, its severity, the action to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 pandemic has subsided, we may experience material adverse impacts on our business as a result of the global economic impact and any recession that has occurred or may occur in the future. There are no comparable recent events that provide guidance as to the effect the spread of COVID-19 as a global pandemic may have, and, as a result, the ultimate impact of the pandemic on our operations and financial results is highly uncertain and subject to change.
We also continue to consider the potential impact of increasing inflation on our business operations. Although no material impairment or other material adverse effects have been identified to date related to such factors, there is substantial uncertainty in the nature and degree of their continued effects over time. That uncertainty could affect management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. Further, although we have not experienced any material adverse effects on our business due to increasing inflation, it has raised operating costs and, in the future, could impact demand or pricing of our products, foreign exchange rates or manpower costs. We are actively monitoring the effects these disruptions and increasing inflation could have on our business operations.
On August 9, 2022, the CHIPS and Science Act of 2022 (CHIPS Act) was enacted in the United States. The CHIPS Act will provide financial incentives to the semiconductor industry which are primarily directed at manufacturing activities within the United States. We continue to evaluate the business impact and potential opportunities related to the CHIPS Act. As of date, we do not see any direct effect of the Act on the Company in the foreseeable future.
There are legal and operational risks associated with having operations in China. These risks could result in a material change in our operations and/or the value of our common stock or could limit or hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless. In recent past, the Peoples Republic of China (“PRC”) government initiated a series of regulatory actions and statements to regulate business operations in China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over China-based companies listed overseas using variable interest entity structure, adopting new measures to extend the scope of cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement.
The Company and its subsidiaries do not have any variable interest entities based in China. Our business primarily consists of semiconductor testing and burn-in services for the automotive industry, avionics, and others. Our businesses are not impacted by anti-monopoly policies, variable interest entities policies, or data security policies, nor are our businesses subject to extraordinary oversight from the Chinese government.
Comparison of the Three Months Ended September 30, 2022, and September 30, 2021
The following table sets forth certain consolidated statements of income data as a percentage of revenue for the three months ended September 30, 2022 and 2021 respectively:
| Three Months Ended |
||||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) | |||||||
| Revenue |
100.0 | % | 100.0 | % | ||||
| Cost of sales |
69.7 | % | 68.8 | % | ||||
| Gross Margin |
30.3 | % | 31.2 | % | ||||
| Operating expense |
||||||||
| General and administrative |
19.3 | % | 19.4 | % | ||||
| Selling |
1.4 | % | 1.4 | % | ||||
| Research and development |
0.6 | % | 1.0 | % | ||||
| Total operating expense |
21.3 | % | 21.8 | % | ||||
| Income from Operations |
9.0 | % | 9.4 | % | ||||
Overall Gross Margin
Overall gross margin as a percentage of revenue decreased by 1.0% to 30.3% for the three months ended September 30, 2022, from 31.2% for the same period of Fiscal 2022.
Gross profit margin as a percentage of revenue in the manufacturing segment decreased by 2.1% to 29.6% for the three months ended September 30, 2022, as compared to 31.7% for the same period in Fiscal 2022. In absolute dollar amounts, gross profits in the manufacturing segment decreased by $68 to $1,060 for the three months ended September 30, 2022, from $1,128 for the same period in Fiscal 2022. The decrease in gross profit margin was primarily due to a higher proportion of lower profit margin product sales for the three months ended September 30, 2022 compared to the same period of Fiscal 2022.
Gross profit margin as a percentage of revenue in the testing segment decreased by 2.2% to 35.2% for the three months ended September 30, 2022, compared to 37.3% in the same period of Fiscal 2022. The decrease in gross profit margin percentage was mainly due to difference in product mix coupled with increased manpower costs. In absolute dollar amounts, gross profit in the testing segment increased by $521 to $2,238 for the three months ended September 30, 2022, from $1,717 for the same period of Fiscal 2022.
Gross profit margin of the distribution segment is not only affected by the market price of the products we distribute, but also the mix of products we distribute, which frequently changes as a result of fluctuations in market demand. Gross profit margin as a percentage of revenue in the distribution segment decreased by 0.2% to 16.9% for the three months ended September 30, 2022, from 17.1% in the same period of Fiscal 2022. In absolute dollar amounts, gross profit in the distribution segment for the three months ended September 30, 2022, was $334, indicating a decrease of $8, compared to $342 in the same period of Fiscal 2022.
In absolute dollar amounts, for the three months ended September 30, 2022, gross loss in the real estate segment was $10, as compared to $8 for the same period of Fiscal 2022.
Operating Expense
Operating Expense for the three months ended September 30, 2022 and 2021 was as follows:
| Three Months Ended |
||||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) | |||||||
| General and administrative |
$ | 2,305 | $ | 1,980 | ||||
| Selling |
173 | 147 | ||||||
| Research and development |
73 | 82 | ||||||
| Gain on disposal of property, plant and equipment |
4 | - | ||||||
| Total |
$ | 2,555 | $ | 2,209 | ||||
General and administrative expense increased by $325, or 16.4%, from $1,980 to $2,305 for the three months ended September 30, 2022, compared to the same period of Fiscal 2022. The increase in general and administrative expense was mainly attributable to the general and administrative expense relating to the Company’s new subsidiary Trio-Tech Jiangsu, which was setup in the third quarter of Fiscal 2022, coupled with increased manpower costs.
Selling expense increased by $26, or 17.7%, from $147 to $173 for the three months ended September 30, 2022, compared to the same period of Fiscal 2022. The increase in selling expense was primarily attributable to an increase in commission costs in the distribution segment of the Singapore operations as a result of an increase in commissionable revenue, and an increase in travel costs due to relaxation of travel restrictions in the first quarter of Fiscal 2023, compared to the same quarter of Fiscal 2022.
Income from Operations
Income from operations was $1,067 for the three months ended September 30, 2022, an increase of $97, compared to profit of $970 from operations for the same period of Fiscal 2022. The result was mainly due to the increased revenue and gross profit margin in absolute dollars amount, offset by the higher operating expense.
Interest Expense
Interest expense for the three months ended September 30, 2022 and 2021 were as follows:
| Three Months Ended |
||||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) | |||||||
| Interest expense |
$ | 44 | $ | 28 | ||||
Interest expense was $44 for the three months ended September 30, 2022, an increase of $16, or 57.1%, compared to $28 for the same period of Fiscal 2022. As of September 30, 2022, the Company had an unused line of credit of $5,289 as compared to $5,397 at September 30, 2021.
Other Income
Other income for the three months ended September 30, 2022 and 2021 were as follows:
| Three Months Ended |
||||||||
| September 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) |
|||||||
| Interest income |
$ | 18 | $ | 22 | ||||
| Other rental income |
27 | 29 | ||||||
| Exchange gain |
70 | 34 | ||||||
| Bad debt recovery |
- | 2 | ||||||
| Dividend income |
- | - | ||||||
| Government grant |
21 | 70 | ||||||
| Other miscellaneous income |
43 | 4 | ||||||
| Total |
$ | 179 | $ | 161 | ||||
Other income increased by $18 from $161 to $179 for the three months ended September 30, 2022 compared to the same period in Fiscal 2022. The increase was primarily contributed by exchange gains partially offset by reduction in government grants received during that period.
In the three months ended September 30, 2022, the Company received government grants amounting to $21 from the local government in the China and Singapore operations.
In the three months ended September 30, 2021, the Company received government grants amounting to $70, of which $42 were the financial assistance received from the Malaysia and Thailand governments amid the COVID-19 pandemic.
Income Tax Expense
The Company's income tax expense was $225 and $180 for the three months ended September 30, 2022, and 2021, respectively. Income tax expense increased due to higher net income coupled with higher GILTI tax provision.
Non-controlling Interest
As of September 30, 2022, we held a 55% interest in Trio-Tech (Malaysia) Sdn. Bhd., Trio-Tech (Kuala Lumpur) Sdn. Bhd., SHI International Pte. Ltd., and 52% interest in PT. SHI Indonesia. We also held a 76% interest in Prestal Enterprise Sdn. Bhd and 51% interest in Trio-tech JiangSu Co. Ltd. The share of non-controlling interest in the net profit from the subsidiaries for the three months ended September 30, 2022 was $96, an increase of $85 compared to the share of non-controlling interest in the net income from the subsidiaries of $11 for the same period of the previous fiscal year. The increase in the net income shared by non-controlling interest in the subsidiaries was attributable to the increase in net income generated by the China operation.
Net Income Attributable to Trio-Tech International Common Shareholders
Net income attributable to Trio-Tech International common shareholders for the three months ended September 30, 2022, was $882, a change of $35, compared to a net income of $917 for the same period Fiscal 2022.
Earnings per Share
Basic earnings per share from continuing operations were $0.22 for the three months ended September 30, 2022, compared to $0.23 for the same period in Fiscal 2022. Basic earnings per share from discontinued operations were $nil for both the three months ended September 30, 2022 and 2021.
Diluted earnings per share from continuing operations were $0.21 for the three months ended September 30, 2022, as compared to $0.23 for the same period in Fiscal 2022. Diluted earnings per share from discontinued operations were $nil for both the three months ended September 30, 2022 and 2021.
Segment Information
The revenue, gross margin and income or loss from operations for each segment during the first quarter of Fiscal 2023 and Fiscal 2022 are presented below. As the revenue and gross margin for each segment have been discussed in the previous section, only the comparison of income or loss from operations is discussed below.
Manufacturing Segment
The revenue, gross margin and income from operations for the manufacturing segment for the three months ended September 30, 2022 and 2021 were as follows:
| Three Months Ended |
||||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) |
|||||||
| Revenue |
$ | 3,585 | $ | 3,562 | ||||
| Gross margin |
29.6 | % | 31.7 | % | ||||
| Income from operations |
$ | 176 | $ | 300 | ||||
Income from operations from the manufacturing segment was $176 compared to income from operations of $300 in the same period of Fiscal 2022, primarily due to a decrease in gross profit margin coupled with an increase in operating expense of $56. Operating expense for the manufacturing segment were $884 and $828 for the three months ended September 30, 2022 and 2021, respectively. The increase in operating expense was mainly due to an increase of $30 in selling expense and an increase of $34 in corporate overhead expense.
Testing Segment
The revenue, gross margin and income from operations for the testing segment for the three months ended September 30, 2022 and 2021 were as follows:
| Three Months Ended |
||||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) |
|||||||
| Revenue |
$ | 6,364 | $ | 4,600 | ||||
| Gross margin |
35.2 | % | 37.3 | % | ||||
| Income from operations |
$ | 581 | $ | 536 | ||||
Income from operations in the testing segment for the three months ended September 30, 2022, was $581, an increase of $45 from income from operations of $536 in the same period of Fiscal 2022. The improvement was mainly attributable to an increase of gross profit. Operating expense was $1,657 and $1,181 for the three months ended September 30, 2022 and 2021, respectively. The increase of $476 in operating expense was mainly due to an increase of $231 in general and administrative expense and an increase of $249 in corporate expense.
Distribution Segment
The revenue, gross margin and income from operations for the distribution segment for the three months ended September 30, 2022 and 2021 were as follows:
| Three Months Ended |
||||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) |
|||||||
| Revenue |
$ | 1,982 | $ | 1,998 | ||||
| Gross margin |
16.9 | % | 17.1 | % | ||||
| Income from operations |
$ | 265 | $ | 254 | ||||
Income from operations in the distribution segment for three months ended September 30, 2022 was $265, compared to $254 for the same period of Fiscal 2022. The increase of $11 was mainly due to a decrease in operating expense. Operating expense were $69 and $88 for the three months ended September 30, 2022 and 2021, respectively.
Real Estate Segment
The revenue, gross margin and loss from operations for the real estate segment for the three months ended September 30, 2022 and 2021 were as follows:
| Three Months Ended |
||||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) |
|||||||
| Revenue |
$ | 8 | $ | 11 | ||||
| Gross margin |
(125.0 | )% | (72.7 | )% | ||||
| Loss from operations |
$ | (14 | ) | $ | (23 | ) | ||
Loss from operations in the real estate segment for the three months ended September 30, 2022, was $14 compared to $23 for the same period of Fiscal 2022. Operating expense were $4 and $15 for the three months ended September 30, 2022 and 2021, respectively.
Corporate
The loss from operations for Corporate for the three months ended September 30, 2022, and 2021 was as follows:
| Three Months Ended |
||||||||
| Sept. 30, |
||||||||
| 2022 |
2021 |
|||||||
| (Unaudited) |
(Unaudited) | |||||||
| Loss from operations |
$ | 58 | $ | (97 | ) | |||
Corporate operating profit was $58 for the three months ended September 30, 2022, compared to loss of $97 in the same period of Fiscal 2022.
Financial Condition
During the three months ended September 30, 2022 total assets increased by $384 to $43,805 compared to $43,421 as of June 30, 2022. The increase was primarily due to increase in inventories, and trade receivables and property, plant and equipment, partially offset by decrease in other receivables, prepaid expenses and operating right-of-use assets.
Cash and cash equivalents were $9,428 as at September 30, 2022, reflecting an increase of $1,730 from $7,698 as at June 30, 2022, primarily due to the maturity of the short-term deposit of Singapore operation for the three months ended September 30, 2022.
Short-term deposits were $2,829 as at September 30, 2022, reflecting a decrease of $2,591 from $5,420 as at June 30, 2022. The decrease was primarily due to maturity of the short-term deposit of Singapore operation for the three months ended September 30, 2022 and reflected in the cash and cash equivalents.
As at September 30, 2022, the trade accounts receivable balance increased by $899 to $12,491, from $11,592 as at June 30, 2022, primarily due to an increase in overall revenue of all entities on a consolidated basis. The number of days’ sales outstanding in accounts receivables for the Group was 79 days and 81 days at the end of the first quarter of Fiscal 2023 and the end of Fiscal 2022, respectively.
Other receivable as at September 30, 2022 mainly comprised of advance payments made to suppliers and refundable services taxes in the Singapore Operation.
Inventories as at September 30, 2022, were $3,548, an increase of $1,290, compared to $2,258 as at June 30, 2022. The increase in inventories was in line with the backlog in the manufacturing segment of our Singapore operations.
Prepaid expense were $631 as at September 30, 2022 compared to $1,215 as at June 30, 2022. This was mainly due to the asset capitalization of down payments made for the purchase of equipment in the China operation.
Investment properties’ net in China was $533 as at September 30, 2022 and $585 as at June 30, 2022. The decrease was primarily due to the foreign currency exchange movement between June 30, 2022 and September 30, 2022.
Property, plant and equipment increased by $206 from $8,481 as at June 30, 2022, to $8,687 as at September 30, 2022, mainly due to the new acquisition of property, plant and equipment in the Singapore and China operations. The increase was partially offset by the depreciation charged for the period and the foreign currency exchange movement between June 30, 2022 and September 30, 2022.
Restricted term deposits decreased by $46 to $1,632 as at September 30, 2022 as compared to $1,678 as at June 30, 2022. This was primarily due to the foreign currency exchange movement between June 30, 2022 and September 30, 2022.
Other assets decreased by $16 to $121 as at September 30, 2022 compared to $137 as at June 30, 2022. This was primarily due to the foreign currency exchange movement between June 30, 2022 and September 30, 2022.
Lines of credit decreased by $447 to $482 as at September 30, 2022 as compared to $929 as at June 30, 2022. This was due to lower utilization of the lines of credit in the Singapore operations.
Accounts payable increased by $1,068 to $3,469 as at September 30, 2022 as compared to $2,401 as at June 30, 2022 which was in line with the increase of inventories.
Accrued expense increased by $175 to $6,179 as at September 30, 2022, as compared to $6,004 as at June 30, 2022. The increase in accrued expense was mainly due to an increase in the accrued purchases and customers’ deposit received in the Singapore operations.
There was no significant change in bank loans payable as it decreased by $2 to $1,742 as at September 30, 2022, as compared to $929 as of June 30, 2022. The loan repayments made by the Malaysia operation during the three months ended September 30, 2022 was offset by the new loan of $175 that was availed to finance purchase of equipment.
Finance leases decreased by $42 to $195 as at September 30, 2022, as compared to $237 as at June 30, 2022. This was due to the repayments made in the Singapore and Malaysia operations.
Operating lease right-of-use assets and the corresponding lease liability decreased by $393 to $2,759 as at September 30, 2022, as compared to $3,152 as at June 30, 2022. This was due to the repayment made and the operating lease expenses charged for the period.
Liquidity Comparison
Net cash provided by operating activities increased by $2,272 to an inflow of $1,561 for the three months ended September 30, 2022, from an outflow of $711 for the same period of Fiscal 2022. The increase in net cash inflow provided by operating activities was primarily due to lower payments made to account payables and accrued expenses by $1,401 and prepaid expense by $1,403. These are partially offset against higher cash outflow for inventories by $979, payments for operating lease $234.
Net cash provided by investing activities increased by $1,249 to an inflow of $1,475 for the three months ended September 30, 2022, from an inflow of $226 for the same period of Fiscal 2022. The increase in cash inflow was primarily due to an increase in withdrawal of unrestricted deposit amounting to $1,822. These increases were partially offset by an increase in additions to property, plant and equipment of $718.
Net cash outflow from financing activities for the three months ended September 30, 2022, was $414, representing a decrease of $431, as compared to cash inflow of $17 during the three months ended September 30, 2021. The decrease was mainly attributable to a higher payment on lines of credit by $637. This decrease was partially offset by an increase in cash inflow $175 from the proceeds from bank loan.
The Company filed the Registration Statement, pursuing to which we may raise capital of US$10,000,000 of any combination of securities (common stock, warrants, debt securities or units) for expansion of the Company’s testing capacity and working capital purposes if necessary.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not applicable.
ITEM 4. CONTROLS AND PROCEDURES
An evaluation was carried out by the Company’s Chief Executive Officer and Chief Financial Officer of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of September 30, 2022, the end of the period covered by this Form 10-Q. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective at a reasonable level.
Changes in Internal Control Over Financial Reporting
There has been no change in the Company’s internal control over financial reporting during the fiscal quarter ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
TRIO-TECH INTERNATIONAL
PART II. OTHER INFORMATION
Not applicable.
Not applicable.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Not applicable.
|
|
Rule 13a-14(a) Certification of Principal Executive Officer of Registrant |
|
|
|
Rule 13a-14(a) Certification of Principal Financial Officer of Registrant |
|
|
|
Section 1350 Certification |
|
| 101.INS |
Inline XBRL Instance Document |
|
| 101.SCH |
Inline XBRL Taxonomy Extension Schema |
|
| 101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase |
|
| 101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase |
|
| 101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase |
|
| 101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase |
|
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
TRIO-TECH INTERNATIONAL |
|
|
|
By: |
/s/ Srinivasan Anitha SRINIVASAN ANITHA Chief Financial Officer (Principal Financial Officer) Dated: November 10, 2022 |
Exhibit 31.1
CERTIFICATIONS
I, S. W. Yong, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Trio-Tech International, a California corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Dated: November 10, 2022
/s/ S. W. Yong
S. W. Yong, Chief Executive Officer
and President (Principal Executive Officer)
Exhibit 31.2
I, Srinivasan Anitha, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Trio-Tech International, a California corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Dated: November 10, 2022
/s/ Srinivasan Anitha
Srinivasan Anitha , Chief Financial Officer (Principal Financial Officer)
Exhibit 32
SECTION 1350 CERTIFICATION
Each of the undersigned, S.W. Yong, President and Chief Executive Officer of Trio-Tech International, a California corporation (the “Company”), and Srinivasan Anitha, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his or her knowledge (1) the quarterly report on Form 10-Q of the Company for the three months ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ S. W. Yong
Name: S. W. Yong
Title: President and Chief Executive Officer
Dated: November 10, 2022
/s/ Srinivasan Anitha
Name: Srinivasan Anitha
Title: Chief Financial Officer
Dated: November 10, 2022
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.